References
- 1. Almholt K., Johnses M.: Stromal cell involvement in cancer. In: Molecular staging of cancer, edited by H. Algayer et al., Springer–Verlag Berlin Heidelberg, 2003, pp. 31–42.
- 2. Beaven M.A.: Our perception of amst cells from Paul Ehrlich to now. Eur J Immunol 2009, 39, 11–25.
- 3. Conti P., Castellani M.L., Kempuraj D., Salini V., Vecchiet J., Tetè S., Mastrangelo F., Perrella A., De Lutiis M.A., Tagen M., Theoharides T.: Role of mast cells in tumor growth. Ann Clin Lab Sci 2007, 37, 315–322.
- 4. Cormier S.A., Taranova A.G., Bedient C., Nguyen T., Protheroe C., Pero R., Dimina D., Ochkur S.I., O'’Neill K., Colbert D., Lombari T.R., Constant S., McGarry M.P., Lee J.J., Lee N.A.: Pivotal advance: eosinophil infiltration of solid tumors is an early and persistent inflammatory host response. J Leukoc Biol 2006, 79, 1131–1139.
- 5. Dabbous M.K., Walker R., Haney L., Carter L.M., Nicolson G.L., Woolley D.E.: Mast cells and matrix degradation at sites of tumor invasion in rat mammary adenocarcinoma. Br J Cancer 1986, 54, 459–465.
- 6. Davis B.P., Rothenberg M.E.: Eosinophils and cancer. Cancer Immunol Res 2014, 2, 1–8.
- 7. Edwards J.G., Swinson D.E.B., Jones J.L., Muller S., Waller D.A., O’Byrne K.J.: Tumor necrosis correlates with angiogenesis and is a predictor of poor prognosis in malignant mesothelioma. Lab Anim Invest 2003, 124, 1916–1923.
- 8. Kashiwase Y., Morioka J., Inamura H., Yoshizawa Y., Usui R., Kurosawa M.: Quantitative analysis of mast cell in benign and malignant breast lesions. Immunohistochemical study on formalin-fixed, paraffin-embedded tissues. Int Arch Allergy Immunol 2004, 134, 199–205.
- 9. Kassayová M., Friedmanová L., Orendáš P., Kubatka P., Bojková B., Bobrov N., Ahlersová E., Ahlers I.: Effect of prolonged psychoemotional stress and melatonin on experimental mammary carcinogenesis in female rats. Neoplasma 2007, 54, 251–255.
- 10. Kubatka P., Kalická K., Bojková B., Ahlers I., Ahlersová E., Péč M.: Neoplastic effect of indomethacin in N-metyl-N-nitrosourea induced mammary carcinogenesis in female rats. Klin Onkol 2012, 25, 359–63.
- 11. Lavalle G.E., Bertagnolli A.C., Tavares W.L.F., Ferreira M.A.N.D., Cassali G.D.: Mast cells and angiogenesis in canine mammary tumor. Arq Bras Med Vet Zootec 2010, 62, 1348–1351.
- 12. Li H., Fan X., Houghton J.M.: Tumor microenvironment: the role of the tumor stroma in cancer. J Cell Biochem 2007, 101, 805–815.
- 13. Maffini M.V., Soto A.M., Calabro J.M., Ucci A.A., Sonnenschein C.: The stroma as a crucial target in rat mammary gland carcinogenesis. J Cell Sci 2004, 15, 1495–1502.
- 14. Molin D., Edström A., Glimelius I., Glimelius B., Nilsson G., Sundström C., Enblad G.: Mast cell infiltration correlates with poor prognosis in Hodgkin’s lymphoma. Br J Haematol 2002, 119, 122–124.
- 15. Pichler M., Hutterer G.C., Chromecki T.F., Jesche J., Kampel-Kettner K., Rehak P., Pummer K., Zigeuner R.: Histologic tumor necrosis is an independent prognostic indicator for clear cell and papillary renal cell carcinoma. Am J Clin Pathol 2012, 137, 283–289.
- 16. Ribatti D., Crivellato E.: Mast cells, angiogenesis, and tumour growth. Biochi Biophys Acta 2012, 1822, 2–8.
- 17. Russo J., Russo I.H.: Atlas and histologic classification of tumors of the rat mammary gland. J Mammary Gland Biol Neoplasia 2000, 5, 187–200.
- 18. Samoszuk M., Deng T., Hamamura M.J., Su M.Y., Asbrock N., Nalcioglu O.: Increased blood clotting, microvascular density, and inflammation in eotaxin-secreting tumors implanted into mice. Am J Pathol 2004, 165, 449–456.
- 19. Samoszuk M., Kanakubo E., Chan J.K.: Degranulating mast cells in fibrotic regions of human tumours and evidence that mast cells’ heparin interferes with the growth of tumour cells through a mechanism involving fibroblasts. BMC Cancer 2005, 5, 121.
- 20. Samoszuk M.: Eosinophils and human cancer. Histol Histopathol 1997, 12, 807–812.
- 21. Saremian J., Rosa M.: Solid papillary carcinoma of the breast: a pathologically and clinically distinct breast tumor. Arch Pathol Lab Med 2012, 136, 1308–1311.
- 22. Schwartz L.B., Bradford T.R., Littman B.H., Wintroub B.U.: The fibrinolytic activity of purified tryptase from human lung mast cells. J Immunol 1985, 135, 2762.
- 23. Schwartz L.B., Lewis R.A., Austen K.F.: Tryptase from human pulmonary mast cells: purification and characterisation. J Biol Chem 1981, 256, 11939.
- 24. Schwartz L.B.: Enzyme mediators of mast cells and basophiles. Clin Rev Allergy 1983, 1, 97.
- 25. Simoes J.P., Shoning P.: Canine mast cell tumors: a comparison of staining techniques. J Vet Diagn Invest 1994, 6, 458–65.
- 26. Stockmann Ch., Schadendorf D., Klose R., Helfrich I.: The impact of the immune system on tumor: angiogenesis and vascular remodelling. Front Oncol 2014, 4, 69.
- 27. Theoharides T.C., Alysandratos K.D., Angelidou A., Zhang B.: Mast cells and tumor microenviroment. In: Cancer drug discovery and development, edited by R.G. Bagley, Springer, New York, 2010, pp. 353–370.
- 28. Theoharides T.C., Cochrane D.E.: Critical role of mast cells in inflammatory diseases and the effect of acute stress. J Neuroimmunol 2004, 146, 1–12.
- 29. Theoharides T.C., Conti P.: Mast cells: the Jekyll and Hyde of tumor growth. Trends Immunol 2004, 25, 235–241.
- 30. Thompson H.J., McGinley J.N., Rothhammer K., Singh M.: Rapid induction of mammary intraductal proliferation, ductal carcinoma in situ and carcinomas by the injection of sexually immature female rats with 1-methyl-1-nitrosourea. Carcinogenesis 1995, 16, 2407–2411.